AKT1 and urinary bladder carcinoma: Based on various lines of evidence, we speculate that NOV may promote bladder cancer progression by activating signaling pathways such as PI3K/AKT and Smad (TGF-β) to induce EMT and enhance the metastatic potential of bladder cancer cells 53, 54.